Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.
Scientific Research Department, Helen Dowling Institute, Bilthoven, The Netherlands.
Eur J Cancer Care (Engl). 2021 Sep;30(5):e13431. doi: 10.1111/ecc.13431. Epub 2021 Mar 25.
Factor structure results of Fear of Cancer Recurrence Inventory (FCRI) translations are inconclusive. Through investigating the factor structure, this study aimed to improve the FCRI and its usability. Therefore, we did a comprehensive comparison of the factor structure results of all translations, by exploring and improving the structure of the Dutch FCRI-NL and by testing this new factor structure in two patient samples.
To compare factor structure results of FCRI translations, we did a literature search using PubMed and Google Scholar. We performed exploratory factor analysis (EFA) in a mixed cancer sample. The confirmatory factor analyses (CFAs) were secondary analyses performed in two randomized controlled trial samples: consecutive breast cancer patients and distressed, mainly breast cancer patients.
All translations showed comparable and reasonable factor structure results; however, the FCRI factor structure can be improved. The EFA resulted in a four-factor solution: fear of cancer recurrence (FCR) severity, cognitive coping, impact of FCR on functioning and behavioural coping. However, the 4-factor CFAs did not fit the sample 2 and 3 data well.
Further exploring the FCRI-NL factor structure did not result in a psychometrically stronger FCRI-NL. Therefore, we recommend retaining the 7-factor FCRI-NL.
恐惧癌症复发量表(FCRI)的翻译版本的因子结构结果并不明确。通过研究因子结构,本研究旨在改进 FCRI 及其可用性。因此,我们通过探索和改进荷兰 FCRI-NL 的结构,并在两个患者样本中测试这种新的结构,对所有翻译的因子结构结果进行了全面比较。
为了比较 FCRI 翻译的因子结构结果,我们使用 PubMed 和 Google Scholar 进行了文献检索。我们在混合癌症样本中进行了探索性因子分析(EFA)。验证性因子分析(CFA)是在两个随机对照试验样本中进行的二次分析:连续乳腺癌患者和苦恼的、主要是乳腺癌患者。
所有翻译的因子结构结果都具有可比性和合理性;然而,FCRI 的因子结构可以进一步改进。EFA 得出了一个四因子解决方案:对癌症复发的恐惧(FCR)严重程度、认知应对、FCR 对功能的影响和行为应对。然而,四因子 CFA 对样本 2 和 3 的数据拟合效果不佳。
进一步探索 FCRI-NL 的因子结构并没有导致 FCRI-NL 的心理测量学上更强。因此,我们建议保留 7 因子的 FCRI-NL。